Moreover, most positive PSA tests are found to be false positives, thus making it an unreliable biomarker for the prediction of PCa [6], thus warranting a need for the development of newer, specific, and reliable biomarkers. This evidence concerns the gene KLK3 and posterior cortical atrophy.